US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cartesian Therapeutics

9.30

+0.02000.22%

Post-market: 9.300.00000.00%19:30 EDT

Volume:112.14K

Turnover:1.03M

Market Cap:281.38M

PE:-1.60

High:9.48

Open:9.16

Low:8.86

Close:9.28

52wk High:11.00

52wk Low:5.60

Shares:30.26M

Float Shares:12.40M

Volume Ratio:1.47

T/O Rate:0.90%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.7983

EPS(LYR):-5.0200

ROE:-7029.26%

ROA:-17.43%

PB:-2.25

PE(LYR):-1.85

Loading ...

Overview Company News Filings

Cartesian Therapeutics grants inducement stock options for 52,450 shares to new hires

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics director Murat Kalayoglu resigns, effective March 31

Insiders' US$1.73m Investments In Red Following Cartesian Therapeutics' US$29m Dip In Market Value

Simply Wall St.

Cartesian Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Cartesian Therapeutics (RNAC)

Cartesian Therapeutics Stock Gains on Full-Year Revenue Beat

Cartesian Therapeutics Raised to Overweight From Neutral by Cantor Fitzgerald

Cartesian Therapeutics Price Target Maintained With a $42.00/Share by Needham

Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald

Cartesian Therapeutics Inc expected to post a loss of 85 cents a share - Earnings Preview

CORRECTION: Cartesian Therapeutics Q4 Adj. EPS $(1.39) Misses $(0.85) Estimate, Sales $947.00K Beat $94.67K Estimate. Adj. EPS excludes Impairment Charges Of $56.7M

Benzinga Earnings

Cartesian Therapeutics FY Sales $2.797M Beat $1.967M Estimate

Benzinga Earnings

Cartesian Therapeutics FY EPS $(5.02) Vs $(4.48) YoY, Cash Balance Of $126.9M To Support Operations Into mid-2027

Benzinga Earnings

Cartesian Therapeutics FY2025 net loss rises 68% to USD 130.3 million

Press Release: Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update

Cartesian Therapeutics (RNAC) Receives a Hold from Cantor Fitzgerald

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/RNAC/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNAC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAC\",,,,,undefined,":{"symbol":"RNAC","market":"US","secType":"STK","nameCN":"Cartesian Therapeutics","latestPrice":9.3,"timestamp":1788292800000,"preClose":9.28,"halted":0,"volume":112137,"hourTrading":{"tag":"盘后","latestPrice":9.3,"preClose":9.3,"latestTime":"19:30 EDT","volume":317,"amount":2948.1,"timestamp":1788305400368,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.002155172413793249,"floatShares":12402686,"shares":30255400,"eps":-5.79826,"marketStatus":"Closed","change":0.02,"latestTime":"09-01 16:00:00 EDT","open":9.16,"high":9.479,"low":8.86,"amount":1028586.949104,"amplitude":0.066703,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.79826,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":5,"adr":0,"listingDate":1466568000000,"exchange":"NASDAQ","adjPreClose":9.28,"preHourTrading":{"tag":"盘前","latestPrice":9.3,"preClose":9.28,"latestTime":"08:47 EDT","volume":140,"amount":1289.87012,"timestamp":1788266844365,"change":0.02,"changeRate":0.002155,"amplitude":0.170259},"postHourTrading":{"tag":"盘后","latestPrice":9.3,"preClose":9.3,"latestTime":"19:30 EDT","volume":317,"amount":2948.1,"timestamp":1788305400368,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.469647,"impliedVol":0.8718,"impliedVolPercentile":0.4722},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAC\",,,,,undefined,":{"symbol":"RNAC","floatShares":12402686,"roa":"-17.43%","roe":"-7029.26%","lyrEps":-5.02,"volumeRatio":1.469647,"shares":30255400,"dividePrice":0,"high":9.479,"amplitude":0.066703,"preClose":9.28,"low":8.86,"week52Low":5.6,"pbRate":"-2.25","psRate":"190.50","week52High":11,"institutionHeld":0,"latestPrice":9.3,"eps":-5.79826,"divideRate":0,"volume":112137,"delay":0,"ttmEps":-5.79826,"open":9.16,"prevYearClose":7.21,"prevWeekClose":9.6,"prevMonthClose":9.28,"prevQuarterClose":10.42,"fiveDayClose":10.38,"twentyDayClose":8.06,"sixtyDayClose":5.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNAC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"RNAC","fiscalQuarterEnding":"2026/06","expectedEps":-0.83,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":0.46},{"market":"US","date":"2026-04-30","symbol":"RNAC","fiscalQuarterEnding":"2026/03","expectedEps":-0.84,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":-1.46},{"market":"US","date":"2026-03-09","symbol":"RNAC","fiscalQuarterEnding":"2025/12","expectedEps":-0.82,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773028800000,"reportTimeType":"pre","actualEps":-1.38},{"market":"US","date":"2025-11-06","symbol":"RNAC","fiscalQuarterEnding":"2025/09","expectedEps":-0.81,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-1.38},{"market":"US","date":"2025-08-07","symbol":"RNAC","fiscalQuarterEnding":"2025/06","expectedEps":-0.76,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":0.5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNAC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNAC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1777608000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNAC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNAC","date":"2026-08-31","current":-1.603929,"percent":0.6144,"low":-14.109752,"twenty":-6.632537,"median":-2.082943,"eighty":-1.491237,"high":-0.322359,"avg":-3.630507,"sd":2.866928,"marketCap":290451379},"quantilePoints":[{"date":"2024-02-09","current":-12.195228,"twenty":-12.293822,"median":-12.139657,"eighty":-11.530164,"marketCap":110159496},{"date":"2024-02-16","current":-13.543282,"twenty":-12.82193,"median":-12.371802,"eighty":-12.018117,"marketCap":122336468},{"date":"2024-02-23","current":-12.9069,"twenty":-13.170416,"median":-12.72226,"eighty":-12.169773,"marketCap":116588031},{"date":"2024-03-01","current":-13.113052,"twenty":-13.187625,"median":-12.9069,"eighty":-12.193077,"marketCap":118450201},{"date":"2024-03-08","current":-0.474472,"twenty":-13.096919,"median":-12.72226,"eighty":-12.104521,"marketCap":104246325},{"date":"2024-03-15","current":-0.394571,"twenty":-13.085087,"median":-12.369113,"eighty":-0.499332,"marketCap":86691095},{"date":"2024-03-22","current":-0.518772,"twenty":-13.077916,"median":-12.18985,"eighty":-0.473381,"marketCap":113979437},{"date":"2024-03-28","current":-0.486782,"twenty":-13.018401,"median":-12.095738,"eighty":-0.472836,"marketCap":106950867},{"date":"2024-04-05","current":-0.371573,"twenty":-12.924109,"median":-11.522994,"eighty":-0.462369,"marketCap":81638284},{"date":"2024-04-12","current":-1.459867,"twenty":-12.9069,"median":-1.226402,"eighty":-0.444134,"marketCap":320747357},{"date":"2024-04-19","current":-1.398365,"twenty":-12.846668,"median":-1.459867,"eighty":-0.462369,"marketCap":307234719},{"date":"2024-04-26","current":-1.691309,"twenty":-12.729072,"median":-1.487381,"eighty":-0.467868,"marketCap":371597548},{"date":"2024-05-03","current":-1.978779,"twenty":-12.63227,"median":-1.536745,"eighty":-0.471303,"marketCap":434757574},{"date":"2024-05-10","current":-1.526348,"twenty":-12.47667,"median":-1.594687,"eighty":-0.472836,"marketCap":389021718},{"date":"2024-05-17","current":-1.839158,"twenty":-12.299559,"median":-1.62026,"eighty":-0.47633,"marketCap":468748036},{"date":"2024-05-24","current":-1.777713,"twenty":-12.193077,"median":-1.671483,"eighty":-0.482182,"marketCap":453087509},{"date":"2024-05-31","current":-2.195259,"twenty":-12.18985,"median":-1.697348,"eighty":-0.489671,"marketCap":559507906},{"date":"2024-06-07","current":-2.422885,"twenty":-12.179811,"median":-1.717665,"eighty":-0.504164,"marketCap":617523039},{"date":"2024-06-14","current":-2.045138,"twenty":-12.139657,"median":-1.777713,"eighty":-0.515905,"marketCap":521246392},{"date":"2024-06-21","current":-1.598266,"twenty":-12.069386,"median":-1.728138,"eighty":-0.518199,"marketCap":407351653},{"date":"2024-06-28","current":-1.991374,"twenty":-11.947846,"median":-1.777713,"eighty":-0.520305,"marketCap":507543431},{"date":"2024-07-05","current":-1.23169,"twenty":-11.531957,"median":-1.728138,"eighty":-0.526438,"marketCap":313922113},{"date":"2024-07-12","current":-1.241477,"twenty":-11.522994,"median":-1.709478,"eighty":-0.530124,"marketCap":316416386},{"date":"2024-07-15","current":-1.240079,"twenty":-9.729226,"median":-1.703386,"eighty":-0.53751,"marketCap":316060062},{"date":"2024-08-02","current":-1.081399,"twenty":-7.935458,"median":-1.699966,"eighty":-0.544895,"marketCap":275617201},{"date":"2024-08-09","current":-1.198323,"twenty":-2.548847,"median":-1.676743,"eighty":-0.772791,"marketCap":275192581},{"date":"2024-08-16","current":-1.345437,"twenty":-2.529995,"median":-1.625846,"eighty":-1.101689,"marketCap":308976908},{"date":"2024-08-23","current":-1.244878,"twenty":-2.507232,"median":-1.598266,"eighty":-1.148418,"marketCap":285883824},{"date":"2024-08-30","current":-1.388267,"twenty":-2.46827,"median":-1.531547,"eighty":-1.172903,"marketCap":318812851},{"date":"2024-09-06","current":-1.307262,"twenty":-2.424002,"median":-1.519153,"eighty":-1.173531,"marketCap":300210089},{"date":"2024-09-13","current":-1.496275,"twenty":-2.390626,"median":-1.497092,"eighty":-1.177113,"marketCap":343616533},{"date":"2024-09-20","current":-1.540036,"twenty":-2.248325,"median":-1.497406,"eighty":-1.182548,"marketCap":353666301},{"date":"2024-09-27","current":-1.616387,"twenty":-2.173184,"median":-1.49772,"eighty":-1.183457,"marketCap":371199939},{"date":"2024-10-04","current":-2.374287,"twenty":-2.173184,"median":-1.519153,"eighty":-1.187433,"marketCap":545250240},{"date":"2024-10-11","current":-2.176603,"twenty":-2.352646,"median":-1.530726,"eighty":-1.193387,"marketCap":499852543},{"date":"2024-10-18","current":-2.257757,"twenty":-2.310612,"median":-1.544226,"eighty":-1.200277,"marketCap":518489492},{"date":"2024-10-25","current":-2.299664,"twenty":-2.339564,"median":-1.569114,"eighty":-1.208188,"marketCap":528113202},{"date":"2024-10-31","current":-2.199769,"twenty":-2.325678,"median":-1.616387,"eighty":-1.208566,"marketCap":505172538},{"date":"2024-11-08","current":-2.028231,"twenty":-2.320475,"median":-1.625846,"eighty":-1.217877,"marketCap":496569789},{"date":"2024-11-15","current":-1.766791,"twenty":-2.31186,"median":-1.676743,"eighty":-1.221601,"marketCap":432561563},{"date":"2024-11-22","current":-1.725268,"twenty":-2.307988,"median":-1.693927,"eighty":-1.221601,"marketCap":422395604},{"date":"2024-11-29","current":-1.954681,"twenty":-2.306323,"median":-1.709478,"eighty":-1.229672,"marketCap":478562529},{"date":"2024-12-06","current":-2.388593,"twenty":-2.306323,"median":-1.725268,"eighty":-1.23169,"marketCap":584796802},{"date":"2024-12-13","current":-2.088591,"twenty":-2.321516,"median":-1.757967,"eighty":-1.238401,"marketCap":511347747},{"date":"2024-12-20","current":-2.024787,"twenty":-2.313583,"median":-1.76875,"eighty":-1.241197,"marketCap":495726646},{"date":"2024-12-27","current":-2.088883,"twenty":-2.309537,"median":-1.777713,"eighty":-1.243092,"marketCap":511419083},{"date":"2025-01-03","current":-1.778913,"twenty":-2.307156,"median":-1.777862,"eighty":-1.244452,"marketCap":435529430},{"date":"2025-01-10","current":-1.777862,"twenty":-2.305849,"median":-1.777862,"eighty":-1.244878,"marketCap":435272177},{"date":"2025-01-17","current":-1.989062,"twenty":-2.304427,"median":-1.779554,"eighty":-1.246554,"marketCap":486980042},{"date":"2025-01-24","current":-2.040548,"twenty":-2.299664,"median":-1.784789,"eighty":-1.253258,"marketCap":499585442},{"date":"2025-01-31","current":-2.036345,"twenty":-2.283748,"median":-1.80308,"eighty":-1.272811,"marketCap":498556430},{"date":"2025-02-07","current":-1.976453,"twenty":-2.276485,"median":-1.8278,"eighty":-1.28026,"marketCap":483893005},{"date":"2025-02-14","current":-1.999569,"twenty":-2.273364,"median":-1.845442,"eighty":-1.299813,"marketCap":489552573},{"date":"2025-02-21","current":-2.060513,"twenty":-2.263946,"median":-1.859179,"eighty":-1.303538,"marketCap":504473250},{"date":"2025-02-28","current":-1.892393,"twenty":-2.258524,"median":-1.87682,"eighty":-1.306703,"marketCap":463312761},{"date":"2025-03-07","current":-1.875581,"twenty":-2.211367,"median":-1.875581,"eighty":-1.307262,"marketCap":459196712},{"date":"2025-03-14","current":-5.557927,"twenty":-2.211367,"median":-1.881886,"eighty":-1.317995,"marketCap":430316947},{"date":"2025-03-21","current":-5.33039,"twenty":-2.277938,"median":-1.88594,"eighty":-1.323353,"marketCap":412700118},{"date":"2025-03-28","current":-4.805047,"twenty":-2.306323,"median":-1.893969,"eighty":-1.325512,"marketCap":372025970},{"date":"2025-04-04","current":-4.129128,"twenty":-2.32984,"median":-1.905491,"eighty":-1.337057,"marketCap":319693626},{"date":"2025-04-11","current":-3.466594,"twenty":-2.375387,"median":-1.926854,"eighty":-1.34432,"marketCap":268397566},{"date":"2025-04-17","current":-3.536863,"twenty":-2.423443,"median":-1.931271,"eighty":-1.357169,"marketCap":273838057},{"date":"2025-04-25","current":-4.03209,"twenty":-2.511189,"median":-1.940728,"eighty":-1.376163,"marketCap":312180567},{"date":"2025-05-02","current":-4.105705,"twenty":-2.552358,"median":-1.945456,"eighty":-1.384171,"marketCap":317880129},{"date":"2025-05-09","current":-7.05935,"twenty":-3.360856,"median":-1.954681,"eighty":-1.385102,"marketCap":270443712},{"date":"2025-05-16","current":-7.066125,"twenty":-3.485332,"median":-1.967259,"eighty":-1.38715,"marketCap":270703255},{"date":"2025-05-23","current":-6.195562,"twenty":-3.649293,"median":-1.975402,"eighty":-1.394326,"marketCap":237351991},{"date":"2025-05-30","current":-6.774808,"twenty":-3.931706,"median":-1.977504,"eighty":-1.416672,"marketCap":259542910},{"date":"2025-06-06","current":-6.327671,"twenty":-4.025398,"median":-1.983808,"eighty":-1.446219,"marketCap":242413077},{"date":"2025-06-13","current":-6.937404,"twenty":-4.149205,"median":-1.989062,"eighty":-1.451731,"marketCap":265771939},{"date":"2025-06-20","current":-6.774808,"twenty":-4.316511,"median":-1.991374,"eighty":-1.456219,"marketCap":259542910},{"date":"2025-06-27","current":-7.76393,"twenty":-4.826462,"median":-1.999044,"eighty":-1.463428,"marketCap":297436174},{"date":"2025-07-03","current":-7.59456,"twenty":-4.979046,"median":-2.003247,"eighty":-1.47767,"marketCap":290947602},{"date":"2025-07-11","current":-9.173091,"twenty":-5.33039,"median":-2.020584,"eighty":-1.478169,"marketCap":351421100},{"date":"2025-07-18","current":-8.488835,"twenty":-5.941507,"median":-2.024838,"eighty":-1.490688,"marketCap":325207266},{"date":"2025-07-25","current":-9.118892,"twenty":-6.287022,"median":-2.028231,"eighty":-1.49255,"marketCap":349344756},{"date":"2025-08-01","current":-8.67853,"twenty":-6.612213,"median":-2.031821,"eighty":-1.496275,"marketCap":332474467},{"date":"2025-08-08","current":-7.544353,"twenty":-6.70706,"median":-2.036345,"eighty":-1.497092,"marketCap":273558227},{"date":"2025-08-15","current":-8.196452,"twenty":-6.774808,"median":-2.042843,"eighty":-1.49772,"marketCap":297203340},{"date":"2025-08-22","current":-7.859415,"twenty":-6.950953,"median":-2.051056,"eighty":-1.50093,"marketCap":284982380},{"date":"2025-08-29","current":-7.371787,"twenty":-7.039026,"median":-2.060422,"eighty":-1.518941,"marketCap":267300991},{"date":"2025-09-05","current":-7.170999,"twenty":-7.05935,"median":-2.070182,"eighty":-1.51928,"marketCap":260020420},{"date":"2025-09-12","current":-7.142315,"twenty":-7.086783,"median":-2.081446,"eighty":-1.524951,"marketCap":258980338},{"date":"2025-09-19","current":-7.3933,"twenty":-7.086783,"median":-2.084663,"eighty":-1.52985,"marketCap":268081053},{"date":"2025-09-26","current":-6.783765,"twenty":-7.148052,"median":-2.088591,"eighty":-1.535541,"marketCap":245979317},{"date":"2025-10-03","current":-7.414813,"twenty":-7.201117,"median":-2.095187,"eighty":-1.539378,"marketCap":268861114},{"date":"2025-10-10","current":-7.242709,"twenty":-7.224056,"median":-2.14643,"eighty":-1.54674,"marketCap":262620624},{"date":"2025-10-17","current":-6.755081,"twenty":-7.209722,"median":-2.173618,"eighty":-1.557355,"marketCap":244939235},{"date":"2025-10-24","current":-6.453899,"twenty":-7.201117,"median":-2.199769,"eighty":-1.567209,"marketCap":234018378},{"date":"2025-10-31","current":-5.81568,"twenty":-7.176736,"median":-2.267478,"eighty":-1.592436,"marketCap":210876560},{"date":"2025-11-07","current":-4.091695,"twenty":-7.170999,"median":-2.283748,"eighty":-1.612763,"marketCap":196315417},{"date":"2025-11-14","current":-3.918507,"twenty":-7.148052,"median":-2.305763,"eighty":-1.619485,"marketCap":188006071},{"date":"2025-11-21","current":-3.875149,"twenty":-7.086783,"median":-2.31186,"eighty":-1.622774,"marketCap":185925782},{"date":"2025-11-28","current":-4.059422,"twenty":-7.068835,"median":-2.325678,"eighty":-1.626335,"marketCap":194767008},{"date":"2025-12-05","current":-3.739654,"twenty":-7.06451,"median":-2.365337,"eighty":-1.65105,"marketCap":179424881},{"date":"2025-12-12","current":-4.579722,"twenty":-7.060984,"median":-2.379788,"eighty":-1.672535,"marketCap":219730470},{"date":"2025-12-19","current":-3.988965,"twenty":-7.05935,"median":-2.423583,"eighty":-1.677012,"marketCap":191386540},{"date":"2025-12-26","current":-3.663777,"twenty":-7.058115,"median":-2.483579,"eighty":-1.682838,"marketCap":175784376},{"date":"2026-01-02","current":-3.907668,"twenty":-7.055526,"median":-2.5116,"eighty":-1.692356,"marketCap":187485999},{"date":"2026-01-09","current":-4.400869,"twenty":-7.049866,"median":-2.540887,"eighty":-1.697913,"marketCap":211149280},{"date":"2026-01-16","current":-3.988965,"twenty":-7.038171,"median":-2.581927,"eighty":-1.705823,"marketCap":191386540},{"date":"2026-01-23","current":-4.1082,"twenty":-7.03475,"median":-3.265826,"eighty":-1.71557,"marketCap":197107333},{"date":"2026-01-30","current":-3.783013,"twenty":-7.03475,"median":-3.400258,"eighty":-1.717665,"marketCap":181505169},{"date":"2026-02-06","current":-3.403628,"twenty":-7.025476,"median":-3.463248,"eighty":-1.725268,"marketCap":163302645},{"date":"2026-02-13","current":-3.474085,"twenty":-7.020408,"median":-3.474085,"eighty":-1.728138,"marketCap":166683114},{"date":"2026-02-20","current":-3.674617,"twenty":-7.019042,"median":-3.506604,"eighty":-1.751586,"marketCap":176304448},{"date":"2026-02-27","current":-4.525524,"twenty":-6.997119,"median":-3.520153,"eighty":-1.758278,"marketCap":217130110},{"date":"2026-03-06","current":-3.728815,"twenty":-6.991626,"median":-3.536863,"eighty":-1.76513,"marketCap":178904809},{"date":"2026-03-13","current":-1.651957,"twenty":-6.985963,"median":-3.528282,"eighty":-1.753846,"marketCap":215253274},{"date":"2026-03-20","current":-1.33662,"twenty":-6.957673,"median":-3.51344,"eighty":-1.717246,"marketCap":174164287},{"date":"2026-03-27","current":-1.236933,"twenty":-6.943412,"median":-3.490344,"eighty":-1.689135,"marketCap":161174865},{"date":"2026-04-02","current":-1.3,"twenty":-6.939053,"median":-3.46763,"eighty":-1.672535,"marketCap":169392663},{"date":"2026-04-10","current":-1.257277,"twenty":-6.933339,"median":-3.403628,"eighty":-1.622146,"marketCap":163825768},{"date":"2026-04-17","current":-1.297966,"twenty":-6.92426,"median":-3.364537,"eighty":-1.565304,"marketCap":169127573},{"date":"2026-04-24","current":-1.417997,"twenty":-6.914189,"median":-2.609701,"eighty":-1.534337,"marketCap":184767897},{"date":"2026-05-01","current":-1.086392,"twenty":-6.894617,"median":-2.546025,"eighty":-1.512742,"marketCap":164886129},{"date":"2026-05-08","current":-1.579672,"twenty":-6.838981,"median":-2.513656,"eighty":-1.499646,"marketCap":239753154},{"date":"2026-05-15","current":-1.600967,"twenty":-6.793804,"median":-2.483579,"eighty":-1.502438,"marketCap":242985120},{"date":"2026-05-22","current":-1.293163,"twenty":-6.778391,"median":-2.422885,"eighty":-1.494785,"marketCap":196268513},{"date":"2026-05-29","current":-1.395764,"twenty":-6.774808,"median":-2.379788,"eighty":-1.483177,"marketCap":211840715},{"date":"2026-06-05","current":-1.267997,"twenty":-6.772654,"median":-2.365337,"eighty":-1.459736,"marketCap":192448916},{"date":"2026-06-12","current":-1.560313,"twenty":-6.766157,"median":-2.325678,"eighty":-1.446219,"marketCap":236815002},{"date":"2026-06-18","current":-1.912642,"twenty":-6.761259,"median":-2.31186,"eighty":-1.450539,"marketCap":290289358},{"date":"2026-06-26","current":-1.728734,"twenty":-6.760023,"median":-2.305763,"eighty":-1.456175,"marketCap":262376920},{"date":"2026-07-02","current":-1.970718,"twenty":-6.755081,"median":-2.291706,"eighty":-1.459648,"marketCap":299103812},{"date":"2026-07-10","current":-1.871989,"twenty":-6.755081,"median":-2.273364,"eighty":-1.459867,"marketCap":284119240},{"date":"2026-07-17","current":-1.612582,"twenty":-6.70706,"median":-2.228763,"eighty":-1.46072,"marketCap":244748011},{"date":"2026-07-24","current":-1.533211,"twenty":-6.70706,"median":-2.176603,"eighty":-1.47767,"marketCap":232701590},{"date":"2026-07-31","current":-1.49643,"twenty":-6.688109,"median":-2.155028,"eighty":-1.47428,"marketCap":227119103},{"date":"2026-08-07","current":-1.694518,"twenty":-6.664384,"median":-2.120969,"eighty":-1.478069,"marketCap":257382062},{"date":"2026-08-14","current":-1.736947,"twenty":-6.655677,"median":-2.088883,"eighty":-1.480388,"marketCap":263826669},{"date":"2026-08-21","current":-2.037726,"twenty":-6.643213,"median":-2.087161,"eighty":-1.488739,"marketCap":309512250},{"date":"2026-08-28","current":-1.985936,"twenty":-6.634099,"median":-2.084439,"eighty":-1.491127,"marketCap":301645859},{"date":"2026-08-31","current":-1.912236,"twenty":-6.632537,"median":-2.082943,"eighty":-1.491237,"marketCap":290451379}],"updateTime":1788318784179},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNAC\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624036105","title":"Cartesian Therapeutics grants inducement stock options for 52,450 shares to new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2624036105","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624036105?lang=en_us&edition=fundamental","pubTime":"2026-04-02 19:05","pubTimestamp":1775127922,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics issued stock options covering 52,450 common shares to two new employees under its Amended and Restated 2018 Employment Inducement Incentive Award Plan.Options carry an exercise price of $6.39, set at Nasdaq closing price on April 1, 2026.Vesting starts with 25% on April 1, 2027, followed by monthly installments through April 1, 2030.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL4xht07:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4588","LU2210150020.SGD","SG9999014005.SGD","IE00BN0W2V16.EUR","BK4112","BK4139","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","NDAQ","IE00B3QW5Z07.USD","SG9999014039.USD","BK4585","SG9999014013.SGD","RNAC","IE00BKPKM429.USD","SG9999014021.USD","LU2095319765.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624505868","title":"Cartesian Therapeutics Announces New Employment Inducement Grants","url":"https://stock-news.laohu8.com/highlight/detail?id=2624505868","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624505868?lang=en_us&edition=fundamental","pubTime":"2026-04-02 19:05","pubTimestamp":1775127900,"startTime":"0","endTime":"0","summary":"FREDERICK, Md., April  02, 2026 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune dise","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/02/3267233/0/en/Cartesian-Therapeutics-Announces-New-Employment-Inducement-Grants.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623324490","title":"Cartesian Therapeutics director Murat Kalayoglu resigns, effective March 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2623324490","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623324490?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:48","pubTimestamp":1774907289,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics director Murat Kalayoglu notified board of intent to resign effective March 31, 2026.Exit ends his roles as chair of Science and Technology Committee plus membership on Nominating and Corporate Governance Committee.Resignation was not tied to any disagreement over company operations, policies, or practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cartesian Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL74m70v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622027278","title":"Insiders' US$1.73m Investments In Red Following Cartesian Therapeutics' US$29m Dip In Market Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2622027278","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622027278?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:52","pubTimestamp":1774435931,"startTime":"0","endTime":"0","summary":"Insiders who bought US$1.73m worth of Cartesian Therapeutics, Inc.'s ( NASDAQ:RNAC ) stock at an average buy price of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rnac/cartesian-therapeutics/news/insiders-us173m-investments-in-red-following-cartesian-thera","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rnac/cartesian-therapeutics/news/insiders-us173m-investments-in-red-following-cartesian-thera","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618928564","title":"Cartesian Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2618928564","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618928564?lang=en_us&edition=fundamental","pubTime":"2026-03-11 21:31","pubTimestamp":1773235870,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryCartesian Therapeutics Inc RNAC.OQ reported a quarterly adjusted loss of $3.57 per share for the quarter ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL8N3ZZ1OE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618608571","title":"Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Cartesian Therapeutics (RNAC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618608571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618608571?lang=en_us&edition=fundamental","pubTime":"2026-03-10 06:30","pubTimestamp":1773095410,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on MacroGenics (MGNX – Research Report) and Cartesian...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-macrogenics-mgnx-and-cartesian-therapeutics-rnac-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-macrogenics-mgnx-and-cartesian-therapeutics-rnac-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","XLV","BK4588","BK4581","XBI","BK4139","LABU","MGNX","RNAC","BK4585","LU0029874061.USD","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618675097","title":"Cartesian Therapeutics Stock Gains on Full-Year Revenue Beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2618675097","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618675097?lang=en_us&edition=fundamental","pubTime":"2026-03-10 01:51","pubTimestamp":1773078660,"startTime":"0","endTime":"0","summary":"Shares of Cartesian Therapeutics rose after the company reported 2025 revenue ahead of Wall Street expectations despite widening its loss for the year.Shares were up 29% to $8.81 in Monday afternoon trading. The stock has fallen 51% over the past year.The biotechnology company reported a full-year loss of $130.3 million, or $5.02 a share, compared with a loss of $77.4 million, or $4.49 a share, a year earlier.Revenue fell to $2.8 million from $38.9 million. Collaboration and licensing revenue fell to $400,000 from $38.3 million, partially offset by a rise in grant revenues to $2.4 million from $638,000.Analysts were expecting a loss of $2.35 a share and $2 million in revenue.The company said it remains on track to deliver on its Phase 3 trial for Descartes-08, a T-cell therapy, to treat myasthenia gravis, a chronic autoimmune disease leading to muscle weakness.It added that is working to a launch a Phase 2 trial for Descartes-08 to treat myositis, a form of chronic muscle inflammation,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cartesian Therapeutics Stock Gains on Full-Year Revenue Beat","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618867323","title":"Cartesian Therapeutics Raised to Overweight From Neutral by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2618867323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618867323?lang=en_us&edition=fundamental","pubTime":"2026-03-10 01:04","pubTimestamp":1773075840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNAC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 09, 2026 13:04 ET (17:04 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618065678","title":"Cartesian Therapeutics Price Target Maintained With a $42.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2618065678","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618065678?lang=en_us&edition=fundamental","pubTime":"2026-03-10 00:34","pubTimestamp":1773074040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNAC/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 09, 2026 12:34 ET (16:34 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618627421","title":"Cartesian Therapeutics upgraded to Overweight from Neutral at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2618627421","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618627421?lang=en_us&edition=fundamental","pubTime":"2026-03-09 23:00","pubTimestamp":1773068451,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald upgraded Cartesian Therapeutics (RNAC) to Overweight from Neutral. Published first on TheFly – the ultimate source for real-time,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cartesian-therapeutics-upgraded-to-overweight-from-neutral-at-cantor-fitzgerald-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cartesian-therapeutics-upgraded-to-overweight-from-neutral-at-cantor-fitzgerald-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618626454","title":"Cartesian Therapeutics Inc  expected to post a loss of 85 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2618626454","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618626454?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:47","pubTimestamp":1773060426,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics Inc  expected to post a loss of85cents a share - Earnings Preview Cartesian Therapeutics Inc RNAC.OQ RNAC.O is expected to  show a fall in quarterly revenue when it reports  res","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL8N3ZX15U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618623202","title":"CORRECTION: Cartesian Therapeutics Q4 Adj. EPS $(1.39) Misses $(0.85) Estimate, Sales $947.00K Beat $94.67K Estimate. Adj. EPS excludes Impairment Charges Of $56.7M","url":"https://stock-news.laohu8.com/highlight/detail?id=2618623202","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618623202?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:58","pubTimestamp":1773057527,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics (NASDAQ:RNAC) reported quarterly losses of $(1.39) per share which missed the analyst consensus estimate of $(0.85) by 62.95 percent. This is a 247.5 percent decrease over losses of $(0.40) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51123903/correction-cartesian-therapeutics-q4-adj-eps-1-39-misses-0-85-estimate-sales-947-00k-beat-94-67k-es","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618628897","title":"Cartesian Therapeutics FY Sales $2.797M Beat $1.967M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2618628897","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618628897?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:12","pubTimestamp":1773054766,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics FY Sales $2.797M Beat $1.967M Estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51122789/cartesian-therapeutics-fy-sales-2-797m-beat-1-967m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618853628","title":"Cartesian Therapeutics FY EPS $(5.02) Vs $(4.48) YoY, Cash Balance Of $126.9M To Support Operations Into mid-2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2618853628","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618853628?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:10","pubTimestamp":1773054654,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics FY EPS $(5.02) Vs $(4.48) YoY, Cash Balance Of $126.9M To Support Operations Into mid-2027","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51122730/cartesian-therapeutics-fy-eps-5-02-vs-4-48-yoy-cash-balance-of-126-9m-to-support-operations-into-mi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618640114","title":"Cartesian Therapeutics FY2025 net loss rises 68% to USD 130.3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2618640114","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618640114?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:02","pubTimestamp":1773054126,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics reported a FY 2025 net loss of USD 130.3 million, or USD 5.02 per share, compared with a 68% wider loss year over year. FY 2025 revenue was USD 2.8 million, down 93% year over year. FY 2025 R&D expense rose 29% to USD 58 million, while general and administrative expense was USD 31.5 million. Cash, cash equivalents and restricted cash totaled USD 126.9 million at Dec. 31, and the company said this is expected to fund operations into mid-2027, including completion of the Phase 3 AURORA trial of Descartes-08 in myasthenia gravis. Management said enrollment is progressing in AURORA toward about 100 patients, and the Phase 2 TRITON trial in myositis is expected to initiate in 1H26 after FDA acceptance of the IND.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL8ZMcWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4588","BK4139","IE00BGHQF748.EUR","RNAC","IE00B64PRP62.GBP","NDAQ","BK4585","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","SG9999014013.SGD","SG9999014039.USD","SG9999014021.USD","LU2210150020.SGD","BK4112","LU2210149790.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618640149","title":"Press Release: Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2618640149","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618640149?lang=en_us&edition=fundamental","pubTime":"2026-03-09 19:00","pubTimestamp":1773054000,"startTime":"0","endTime":"0","summary":"Enrollment continues to progress in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis. Phase 2 TRITON trial of Descartes-08 in dermatomyositis and antisynthetase syndrome, expected to initiate in 1H26. FREDERICK, Md., March 09, 2026  -- Cartesian Therapeutics, Inc.  , a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today reported financial results for the year ended December 31, 2025, and outlined recent business updates.\"Building on a productive year, we look forward to a potentially transformative 2026 as we advance Descartes-08 across several autoimmune indications,\" said Carsten Brunn, Ph.D., President and Chief Executive Officer of Cartesian. \"Our top priority remains delivering on our Phase 3 AURORA trial in myasthenia gravis , for which we are on track to enroll approximately 100 patients. This trial represents a crucial opportunity to demonstrate the potential of Descartes-08 to improve patient outcomes and redefine the stand","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","IE00B7SZL793.SGD","IE00B66KJ199.SGD","BK4139","IE00B19Z4B17.USD","MG","BK4123","RNAC","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614865481","title":"Cartesian Therapeutics (RNAC) Receives a Hold from Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2614865481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614865481?lang=en_us&edition=fundamental","pubTime":"2026-02-28 01:09","pubTimestamp":1772212143,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Kristen Kluska maintained a Hold rating on Cartesian Therapeutics yesterday and set a price target of $16.00. According t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cartesian-therapeutics-rnac-receives-a-hold-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cartesian-therapeutics-rnac-receives-a-hold-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RNAC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613781513","title":"Cartesian Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2613781513","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613781513?lang=en_us&edition=fundamental","pubTime":"2026-02-23 20:00","pubTimestamp":1771848000,"startTime":"0","endTime":"0","summary":"FREDERICK, Md., Feb.  23, 2026  (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases,","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/23/3242469/0/en/Cartesian-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":78,"code":"91000000","status":"200"}]}}